|
🐜
|
Upgrade in Gleason score between prostate biopsies and pathology following radical prostatectomy significantly impacts upon the risk of biochemical recurrence
10 auth.
N. Corcoran,
Matthew K. H. Hong,
R. Casey,
A. Hurtado-coll,
J. Peters,
L. Harewood,
...
S. Goldenberg,
C. Hovens,
A. Costello,
M. Gleave
|
6 |
2011 |
6
🐜
|
|
🦁
|
Laparoscopic ureterolithotomy: the results of an initial series, and an evaluation of its role in the management of ureteric calculi.
L. Harewood,
David R Webb,
A. Pope
|
6 |
1994 |
6
🦁
|
|
🐜
|
Human Epithelial Basal Cells Are Cells of Origin of Prostate Cancer, Independent of CD133 Status
9 auth.
Renea A. Taylor,
Roxanne Toivanen,
M. Frydenberg,
J. Pedersen,
L. Harewood,
Australian Prostate Cancer Bioresource,
...
A. Collins,
N. Maitland,
G. Risbridger
|
6 |
2012 |
6
🐜
|
|
🐜
|
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy.
52 auth.
M. Lawrence,
D. Obinata,
S. Sandhu,
L. Selth,
S. Wong,
L. Porter,
N. Lister,
D. Pook,
C. Pezaro,
D. Goode,
R. Rebello,
A. Clark,
M. Papargiris,
Jenna Van Gramberg,
Adrienne R Hanson,
...
P. Banks,
Hong Wang,
B. Niranjan,
Shivakumar Keerthikumar,
S. Hedwards,
Alisee Huglo,
Rendong Yang,
C. Henzler,
Yingming Li,
F. López-Campos,
E. Castro,
Roxanne Toivanen,
A. Azad,
D. Bolton,
J. Goad,
J. Grummet,
L. Harewood,
J. Kourambas,
N. Lawrentschuk,
D. Moon,
D. Murphy,
S. Sengupta,
R. Snow,
H. Thorne,
C. Mitchell,
J. Pedersen,
D. Clouston,
Sam Norden,
A. Ryan,
S. Dehm,
W. Tilley,
R. Pearson,
R. Hannan,
M. Frydenberg,
L. Furic,
Renea A. Taylor,
G. Risbridger
|
6 |
2018 |
6
🐜
|
|
🐜
|
Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumours
11 auth.
N. Corcoran,
C. Hovens,
Matthew K. H. Hong,
J. Pedersen,
R. Casey,
S. Connolly,
...
J. Peters,
L. Harewood,
M. Gleave,
S. Goldenberg,
A. Costello
|
6 |
2012 |
6
🐜
|
|
🐜
|
The ability of prostate‐specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume
11 auth.
N. Corcoran,
R. Casey,
Matthew K. H. Hong,
J. Pedersen,
S. Connolly,
J. Peters,
...
L. Harewood,
M. Gleave,
A. Costello,
C. Hovens,
S. Goldenberg
|
6 |
2012 |
6
🐜
|
|
🐜
|
A case–control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects
10 auth.
J. Beilin,
L. Harewood,
M. Frydenberg,
H. Mameghan,
Raymond F. Martyres,
Stephen J. Farish,
...
Chen Yue,
David R. Deam,
Keith Byron,
J. Zajac
|
6 |
2001 |
6
🐜
|
|
🐜
|
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology
45 auth.
G. Risbridger,
A. Clark,
L. Porter,
Roxanne Toivanen,
A. Bakshi,
N. Lister,
D. Pook,
C. Pezaro,
S. Sandhu,
Shivakumar Keerthikumar,
Rosalía Quezada Urban,
M. Papargiris,
J. Kraska,
H. Madsen,
Hong Wang,
...
M. Richards,
B. Niranjan,
Samantha O'Dea,
Linda Teng,
William Wheelahan,
Zhuoer Li,
Nicholas K Choo,
John F. Ouyang,
Heather Thorne,
L. Devereux,
R. Hicks,
S. Sengupta,
L. Harewood,
Mahesh Iddawala,
A. Azad,
J. Goad,
J. Grummet,
J. Kourambas,
E. Kwan,
D. Moon,
D. Murphy,
J. Pedersen,
D. Clouston,
Sam Norden,
A. Ryan,
L. Furic,
D. Goode,
M. Frydenberg,
M. Lawrence,
Renea A. Taylor
|
5 |
2021 |
5
🐜
|
|
🐜
|
Positive surgical margins are a risk factor for significant biochemical recurrence only in intermediate‐risk disease
11 auth.
N. Corcoran,
C. Hovens,
Charles Metcalfe,
Matthew K. H. Hong,
J. Pedersen,
R. Casey,
...
J. Peters,
L. Harewood,
S. Goldenberg,
A. Costello,
M. Gleave
|
5 |
2012 |
5
🐜
|
